HD Focus

News Across the Globe

Support our Christmas campaign and help ensure Huntington’s families have the support they need

Support our Christmas campaign and help ensure Huntington's families have the support they need - Scottish Huntington's Association

Every journey is easier when you have someone you can trust by your side. Imagine a relentless disease that impacts […]

Arexera Therapeutics Highlights Potentially Best-in-Class Preclinical Profile and Initiates Clinical Development for ATL-101 in Huntington’s Disease

News - Huntington's Disease Society of America

https://www.globenewswire.com/news-release/2026/11/16/3403222/0/en/arexera-therapeutics-highlights-potentially-best-in-class-preclinical-profile-and-initiates-clinical-development-for-atl-101-in-huntington-s-disease.html?_gl=1*1a13gs6*_up*MQ..*_ga*NDQ4OTY4MzkwLjE3OTQ4NzQxNjQ.*_ga_B6167QB2TF*czE3OTQ4NzQxNjQkbzEkZzAkdDE3OTQ4NzQxNjckajU3JGwwJGgyMDg2NTczMDg0*_ga_ERWPGTJ5X8*czE3OTQ4NzQxNjQkbzEkZzAkdDE3OTQ4NzQxNjckajU3JGwwJGgw

The post Arexera Therapeutics Highlights Potentially Best-in-Class Preclinical Profile and Initiates Clinical Development for ATL-101 in Huntington’s Disease first appeared on Huntington's Disease Society of America.

“A Whole World of Unknown”: How Couples Live Between Today and Tomorrow with HD

Enroll

When Huntington’s disease is part of your future, how do you live in the present? New research explores the experiences of partners navigating uncertainty and hope while living with HD.

Huntingtondag 2027: Ben jij erbij?

Nieuws - Vereniging van Huntington

Op 15 mei 2027 komt de Huntington-gemeenschap samen in Ede. Mensen met Huntington, naasten, onderzoekers, zorgprofessionals en andere betrokkenen, allemaal op één plek.

De komende maanden maken we steeds meer bekend over het programma. Maar vanaf vandaag kun je al laten weten dat je erbij wilt zijn!

Gezocht: cliënten en naasten van mensen met Huntington

Nieuws - Vereniging van Huntington

Voor een afstudeeronderzoek aan de Christelijke Hogeschool Ede (i.s.m. Atlant) wordt onderzocht hoe maatschappelijk werkers gezinnen waarin Huntington voorkomt het beste kunnen ondersteunen. En daar is jouw ervaring voor nodig!

Heb jij zelf Huntington? Of ben je partner, ouder, kind, broer, zus of een andere naaste?

Teva responde ofício da ABH com esclarecimentos sobre o processo da deutetrabenazina na Conitec

ABH – Associação Brasil Huntington

A companhia confirma que o recurso foi negado, resume os argumentos apresentados e estima nova submissão à Conitec no primeiro semestre de 2027

O post Teva responde ofício da ABH com esclarecimentos sobre o processo da deutetrabenazina na Conitec apareceu primeiro em ABH – Associação Brasil Huntington.

EHDN 2026 Part 2: What’s the latest news for Huntington’s disease clinical trials?

Enroll

From huntingtin-lowering medicines to gene therapies and new approaches to clinical trials, EHDN 2026 brought plenty of updates on treatments being tested in people with Huntington’s disease. Here’s what we learned.

EHA overhandigt brief aan EMA

Nieuws - Vereniging van Huntington

Op 5 november heeft de European Huntington Association een brief overhandigd aan het Europees Geneesmiddelenbureau (EMA) in Amsterdam. Zij deed dit onder andere in aanwezigheid van ons bestuurslid Hans Polder en voorzitter van de Vereniging van Huntington Rob Haselberg. De organisatie licht de overhandiging toe:

"Onze voorzitter, Astri Arnesen, werd vergezeld door vier vertegenwoordigers van de Huntington-gemeenschap om deze brief te bezorgen. We werden ontvangen door Maria Mavris en Kaisa Immonen, de patiëntencontactpersonen van het EMA. Ze luisterden naar wat we te zeggen hadden, namen de brief in ontvangst en bedankten ons. Ze lieten ons weten dat ze de brief zullen doorsturen naar de betrokkenen binnen het EMA en naar de uitvoerend directeur, Emer Cooke.

Video från utbildningsdagen – 15 oktober

RHS Riksförbundet Huntingtons Sjukdom

Nu finns videoinspelningen från utbildningsdagen den 15 oktober uppe och tillgänglig här

Inlägget Video från utbildningsdagen – 15 oktober dök först upp på RHS Riksförbundet Huntingtons Sjukdom.

EHDN 2026 Part 1: What’s next in the Huntington’s disease treatment pipeline?

HDBuzz

From stopping CAG repeats from growing to finding new ways to tackle harmful huntingtin, scientists at the EHDN Clinical Research Congress 2026 shared exciting ideas for the next generation of HD treatments. Here's what's coming down the pipeline.

Join Us Now for HIPE Virtual Facing the Unknown with Hope

Help 4 HD International

Virtual HIPE ~ Facing the Unknown with Hope Sat, Nov 07 Virtual Event Join us tomorrow! Join from PC, Mac, iPad, or Android: https://us02web.zoom.us/j/85805545293?pwd=YMas9a38qgrVNcuwxR8ksiUh5lW9V4.1 Passcode:320676 We are also streaming on YouTube: https://www.youtube.com/@help4hdtv Facebook: https://www.facebook.com/help4hd/ Nov 07, 2026, 7:45 AM – 2:00 PM PST Virtual Event

First US participants receive SKY-1505, experimental HD treatment

Huntington's Australia

In an update today, Skyhawk Therapeutics announced that the first participants in its United States study trial for...

Skyhawk Therapeutics Announces First U.S. Patients Dosed in Pivotal FALCON-HD Study Evaluating SKY-0515 in Huntington’s Disease

News - Huntington's Disease Society of America

Skyhawk’s drug trial takes flight in the US

Enroll

Skyhawk’s FALCON-HD trial has dosed the first participants in the US with the drug, SKY-0515. The once-daily pill targets two drivers of HD, but does it actually slow disease? That’s the big question this study hopes to answer.

FALCON-HD: primeiros participantes recebem doses do medicamento experimental nos EUA

ABH – Associação Brasil Huntington

Skyhawk anuncia as primeiras doses do SKY-0515 nos EUA. O comunicado não traz novos dados de eficácia

O post FALCON-HD: primeiros participantes recebem doses do medicamento experimental nos EUA apareceu primeiro em ABH – Associação Brasil Huntington.

Skyhawk Community Letter

News - Huntington's Disease Society of America

Skyhawk Therapeutics Announces First U.S. Patients Dosed in Pivotal FALCON-HD Study Evaluating SKY-0515 in Huntington's Disease

Help 4 HD International

Mayke Oosterloo: “Ik wil de stem van patiënten en naasten meenemen naar Europees niveau”

Nieuws - Vereniging van Huntington

Tijdens het recente EHDN congres in Krakau is Mayke Oosterloo benoemd tot lid van het Executive Committee. In gesprek met de Vereniging van Huntington vertelt ze over wat dit inhoudt en hoe ze haar benoeming kan inzetten om mensen te helpen.

uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington’s Disease

Help 4 HD International

U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for ifezuntirgene inilparvovec (eye-feh-ZUN teer-JEEN in-il-par-VOE-vek) (also referred to as AMT-130), an investigational gene therapy candidate for the treatment of Huntington’s disease, for review

UniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the

News - Huntington's Disease Society of America

uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the

The post UniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the first appeared on Huntington's Disease Society of America.